Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy

Abstract

Our results set forth the importance of skin DC in cancer immunotherapy, and demonstrates that restoring DC function is key to enhancing tumor immunogenicity and subsequently responsiveness to checkpoint blockade therapy.